MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.medine.2026.502544

Медицинская библиотека · Medicina intensiva · 2026

Impact of beta-blockers on cardiovascular outcomes in myocardial infarction patients with preserved or mildly reduced ejection fraction: Systematic review and meta-analysis of randomized trials.

Neira-Chunga Leonardo David, Moncada-Gutiérrez Diego Alexis, Vásquez-Tirado Gustavo Adolfo, Morales-Piscoya Marcos Israel, Guzmán-Aguilar Wilson Marcial, Quispe-Castañeda Claudia Vanessa, Meregildo-Rodríguez Edinson Dante, Farfán-Castillo Angie, Serna-Alarcón Víctor, Ortiz-Pizarro Mariano, Villarreal-Jara Milene

СтатьяСистематический обзорМетаанализПеревод пока не подготовлен

Аннотация

OBJECTIVE

To evaluate the association between beta-blocker therapy and major cardiovascular outcomes in patients with acute myocardial infarction (AMI) and preserved or mildly reduced left ventricular ejection fraction (LVEF).

DESIGN

Systematic review and meta-analysis of randomized clinical trials.

SETTING

A comprehensive search of five electronic databases was conducted using a predefined PICO strategy to identify published studies. Seven studies were selected and included in the meta-analysis.

PARTICIPANTS

Patients with AMI and preserved or mildly reduced LVEF who received beta-blocker therapy.

INTERVENTION: Use of beta-blockers.

MAIN OUTCOME MEASURES: Primary composite outcome including mortality, reinfarction, cardiovascular-related hospitalization, and other cardiovascular events.

RESULTS

This meta-analysis included four studies comprising a total of 18,504 patients with a history of AMI and an LVEF ≥ 40%. Among them, 2223 patients had mildly reduced LVEF, while 15,908 belonged to the preserved LVEF group. Beta-blocker therapy did not reduce the primary composite outcome (death, reinfarction, and hospitalization) in patients with LVEF ≥ 40% (hazard ratio [HR]: 0.90; 95% confidence interval [95% CI]: 0.81-1.01). Subsequent subgroup analyses showed that beta-blocker therapy did not reduce the primary composite outcome in patients with preserved LVEF (HR: 0.94; 95% CI: 0.87-1.03); however, in patients with mildly reduced LVEF, it was associated with a reduction in the same primary composite outcome (HR: 0.82; 95% CI: 0.70-0.97).

CONCLUSIONS

In this meta-analysis, beta-blocker use was not associated with a significant reduction in the primary composite outcome or in mortality or reinfarction. The association observed in patients with mildly reduced ejection fraction derives from a subgroup and should be interpreted with caution in the context of an overall neutral result.

Для цитирования: Neira-Chunga Leonardo David, Moncada-Gutiérrez Diego Alexis, Vásquez-Tirado Gustavo Adolfo, Morales-Piscoya Marcos Israel, Guzmán-Aguilar Wilson Marcial, Quispe-Castañeda Claudia Vanessa, Meregildo-Rodríguez Edinson Dante, Farfán-Castillo Angie, Serna-Alarcón Víctor, Ortiz-Pizarro Mariano, Villarreal-Jara Milene. Impact of beta-blockers on cardiovascular outcomes in myocardial infarction patients with preserved or mildly reduced ejection fraction: Systematic review and meta-analysis of randomized trials.. Medicina intensiva. 2026. DOI: 10.1016/j.medine.2026.502544.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.